Imprint logo
Journal logo

Unlabelled image

J. Garay, A. Kiayias, N. Leonardos, The Bitcoin Backbone Protocol: Analysis and 
Applications, Springer, Berlin, 2015, https://link.springer.com/chapter/ 
10.1007/978-3-662-46803-6_10 

S.B. Thorat, S.K. Banarjee, D.D. Gaikwad, S.L. Jadhav, R.M. Thorat, Clinical trial: 
a review, International Journal of Pharmaceutical Sciences Review and 
Research. (2010) 101–106 

K.E. Peace, D.-G. Chen, Clinical Trial Methodology, CRC Press, Chapman & Hall/ 
CRC Biostatistics Series, 2010 

F. Angeletti, I. Chatzigiannakis, A. Vitaletti, The role of blockchain and IoT in 
recruiting participants for digital clinical trials, 25th International Conference 
on Software, Telecommunications and Computer Networks (SoftCOM), 2017 

P. Schueler, B. Buckley, Re-Engineering Clinical Trials-Best Practices for 
Streamlining the Development Process, Academic Press, New York, 2014, 
https://www.elsevier.com/books/re-engineering-clinical-trials/schueler/978- 
0-12-420246-7 


Springer International Publishing, 2018, pp. 75–91.: http://link.springer.com/ 
10.1007/978-3-319- 94478-4. 
[37] J.C. Kvedar, A.L. Fogel, mHealth advances clinical research, bit by bit, Nat 
Biotech. 35 (2017) 337–1334, https://doi.org/10.1038/nbt.3851. 
[38] T.-T. Kuo, H.-E. Kim, L. Ohno-Machado, Blockchain distributed ledger 
technologies for biomedical and health care applications, J. Am. Med. Inform. 
Assoc. 24 (2017) 1211–1220, https://doi.org/10.1093/jamia/ocx068. 
[39] T. Nugent, D. Upton, M.Cimpoesu,Improving data transparency in clinical trials 
using blockchainsmart contracts, F1000Res.5 (2016) 2541. https://doi.org/ 
10.12688/f1000research.9756.1. 
[40] M. Benchoufi, R.Porcher, P.Ravaud, Blockchain protocols in clinical trials: 
Transparency andtraceability of consent, F1000Res.6 (2017) 66. https://doi. 
org/10.12688/f1000research.10531.5. 
[41] A. Ekblaw, A. Azaria,MedRec: Medical Data Management on the Blockchain, 
Viral Communications.(2016) 1-10. https://www.media.mit.edu/publications/ 
medrec/. 
[42] H. Kakavand, N. Kost De Sevres, B. Chilton, The blockchain revolution: an 
analysis of regulation and technology related to distributed ledger 
technologies, SSRN. 2017. https://doi.org/10.2139/ssrn.2849251 
[43] P. Filippi, S. Hassan, Blockchain technology as a regulatory technology: from 
code is law to law is code, First Monday. 21 (2016), https://doi.org/10.5210/fm. 
v21i12.7113. 
[44] Food and Drug Administration, Impact of Certain Provisions of the Revised 
Common Rule on FDA-Regulated Clinical Investigations: Guidance for 
Sponsors, Investigators, and Institutional Review Boards, Silver Spring, MD, 
2018. https://www.regulations.gov/contentStreamer?documentId=FDA-2018- 
D-3551-0001&attachmentNumber=1&contentType=pdf (Accessed 2 March 
2021). 
[45] Food and Drug Administration, Regulations: Good Clinical Practice and Clinical 
Trials, 2018. https://www.fda.gov/science-research/clinical-trials-andhuman-
subject-protection/regulations-good-clinicalpractice-and-clinicaltrials 
(Accessed 2 March 2021) 
[46] Food and Drug Administration, Use of Electronic Records and Electronic 
Signatures in Clinical Investigations Under 21 CFR Part 11 - Questions and 
Answers: Guidance for Industry (draft), Silver Spring, MD, 2017. https://www. 
fda.gov/media/105557/download (Accessed 2 March 2021) 
[47] AAHRPP, Tip Sheet 2: Determining Whether an Activity Is Research Involving 
Human Participants, Washington, DC: Association for the Accreditation of 
Human Research Protection Programs, Inc, 2017. https://admin.aahrpp.org/ 
Website%20Documents/Tip_Sheet_2_Determining_Whether_an%20_Activity_ 
is_Research_Involving_Human_Participants.PDF (Accessed 2 March 2021). 
[48] Office for Civil Rights, Is a Software Vendor a Business Associate of a Covered 
Entity? Washington, DC, 2002. https://www.hhs.gov/hipaa/forprofessionals/
faq/256/is-software-vendor-business-associate/index.html 
(Accessed 2 March 2021). 
[50] S.M.C. Gibbons, J. Kaye, A. Smart, C. Heeney, M. Parker, Governing genetic 
databases: challenges facing research regulation and practice, J.L. Soc. 34 
(2007) 163–189, https://doi.org/10.1111/j.1467-6478.2007.00387.x. 
[51] R.S. Dokholyan, L.H. Muhlbaier, J.M. Falletta, J.P. Jacobs, D. Shahian, C.K. Haan, 
E.D. Peterson, Regulatory and ethical considerations for linking clinical and 
administrative databases, Am. Heart J. 157 (2009) 971–982, https://doi.org/ 
10.1016/j.ahj.2009.03.023. 
[52] J. Pollak, HIPAA Questions and Answers Relating to Research Databases, 
Baltimore, MD: Johns Hopkins Medicine, 2006. : https://www. 
hopkinsmedicine.org/institutional_review_board/hipaa_ 
research/faq_databases.html (Accessed 5 March 2021) 
[53] Office for Civil Rights, Research, Washington, DC: Department of Health and 
Human Services, 2017. Available online at: https://www.hhs.gov/ 
hipaa/forprofessionals/special-topics/research/index.html (Accessed 5 March 
2021) 
[54] Office for Human Research Protections, Human Subject RegulationDecision 
Charts, Rockville, MD, 2016. https://www.hhs.gov/ohrp/regulations-andpolicy/
decision-charts/index.html (Accessed 5 March 2021). 

[55] Office for Human Research Protections, Coded Private Information or 

Specimens Use in Research, Guidance, Rockville, MD, 2008. Available online 
at: https://www.hhs.gov/ohrp/regulations-and-policy/guidance/ 
researchinvolving-coded-privateinformation/index.html (Accessed 5 March 
2021). 
[56] M. Benchoufi, P. Ravaud, Blockchain technology for improving clinical research 
quality, Trials 18 (2017) 335, https://doi.org/10.1186/s13063-017-2035-z. 
[57] National Institutes of Health, Notice of Changes to NIH Policy for Issuing 
Certificates of Confidentiality. Bethesda, MD, 2017. https://grants. 
nih.gov/grants/guide/notice-files/NOT-OD-17-109.html (Accessed 5 March 
2021). 
[58] Office for Civil Rights, How Do HIPAA Authorizations Apply to an Electronic 
Health Information Exchange Environment? Washington, DC, 2008. https:// 
www.hhs.gov/hipaa/for-professionals/faq/554/how-do-hipaa-authorizationsapply-
to-electronic-health-information/index.html (Accessed 5 March 2021). 
[59] National Institutes of Health, Common Data Element (CDE) Resource Portal, 
Bethesda, National Library of Medicine, MD, 2019, https://www.nlm.nih.gov/ 
cde/ (Accessed 5 March 2021) 

Food and Drug Administration, Providing Regulatory Submissions in 
Electronic Format-Standardized Study Data: Guidance for Industry, Silver 
Spring, MD, 2014, https://www.fda.gov/media/82716/download (Accessed 7 
March 2021) 

Food and Drug Administration, Electronic Source Data in Clinical 
Investigations, Silver Spring, MD, 2013, https://www.fda.gov/media/ 
85183/download (Accessed 7 March 2021) 

Food and Drug Administration, IRB Waiver or Alteration of Informed Consent 
for Clinical Investigations Involving No More Than Minimal Risk to Human 
Subjects: Guidance for Sponsors, Investigators, and Institutional Review 
Boards, Silver Spring, MD, 2017, https://www.fda.gov/regulatoryinformation/
search-fda-guidance-documents/irb-waiveror-alterationinformed-
consent-clinical-investigations-involving-no-moreminimal-risk 
(Accessed 7 March 2021) 

A.M. Tang, M. Jian, Deep Learning Applications for Cyber Security, Springer, 
Berlin, 2019 

J.H. Hartman, I. Murdock, T. Spalink, The Swarm scalable storage system, In: 
19th IEEE International Conference on Distributed Computing Systems, 1999 


